Physician profile
Timothy Takach
NPI 1386105740
$351.72
in general payments reported to CMS, 2019-2025
11 companies · $24.86 in 2025
The $24.86 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $39.18 · 2023: $64.67 · 2024: $105 · 2025: $24.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $104.81 | 2021 | |
| Astellas Pharma US INC | $64.28 | 2023-2024 | Veozah |
| Lilly USA, LLC | $51.68 | 2021-2024 | Mounjaro, Zepbound |
| Insulet Corporation | $24.86 | 2025 | Omnipod |
| Otsuka America Pharmaceutical, INC. | $23.24 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.07 | 2023 | Camzyos |
| Organon LLC | $15.94 | 2022 | |
| Exact Sciences Corporation | $15.52 | 2024 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $15.31 | 2024 | Qelbree |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $13.77 | 2024 | |
| Kerecis Limited | $6.24 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Takach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.